tiprankstipranks
Vitrolife AB (GB:0YAY)
LSE:0YAY

Vitrolife AB (0YAY) Income Statement

0 Followers

Vitrolife AB Income Statement

Last quarter (Q4 2022), Vitrolife AB's total revenue was kr855.00M, an increase of 66.27% from the same quarter last year. In Q4, Vitrolife AB's net income was kr74.00M. See Vitrolife AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
kr 3.23Bkr 3.23Bkr 1.68Bkr 1.25Bkr 1.48Bkr 1.15B
Cost of Revenue
kr 1.45Bkr 1.45Bkr 634.71Mkr 477.90Mkr 541.48Mkr 390.22M
Gross Profit
kr 1.78Bkr 1.78Bkr 1.05Bkr 767.67Mkr 938.65Mkr 761.12M
Operating Expense
kr 1.15Bkr 1.15Bkr 619.68Mkr 391.86Mkr 450.47Mkr 372.05M
Operating Income
kr 635.00Mkr 635.00Mkr 426.41Mkr 375.81Mkr 488.19Mkr 389.07M
Net Non Operating Interest Income Expense
kr -59.00Mkr -58.00Mkr -9.96Mkr -1.32Mkr -746.00Kkr 829.00K
Other Income Expense
------
Pretax Income
kr 537.00Mkr 537.00Mkr 459.97Mkr 366.19Mkr 492.69Mkr 398.58M
Tax Provision
kr 144.00Mkr 143.00Mkr 116.41Mkr 78.33Mkr 108.86Mkr 87.89M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr 394.00Mkr 394.00Mkr 340.97Mkr 286.85Mkr 382.79Mkr 309.70M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
kr 2.60Bkr 2.60Bkr 1.25Bkr 869.76Mkr 991.95Mkr 762.28M
Net Income From Continuing And Discontinued Operation
kr 394.00Mkr 394.00Mkr 340.97Mkr 286.85Mkr 382.79Mkr 309.70M
Normalized Income
kr 394.00Mkr 407.21Mkr 339.33Mkr 280.17Mkr 383.25Mkr 308.79M
Interest Expense
-kr 44.00Mkr 10.36Mkr 2.08Mkr 2.30Mkr 476.00K
EBIT
kr 581.00Mkr 581.00Mkr 470.33Mkr 368.28Mkr 495.00Mkr 399.06M
EBITDA
kr 581.00Mkr 977.00Mkr 579.25Mkr 452.35Mkr 594.39Mkr 483.75M
Currency in SEK

Vitrolife AB Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis